Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C L Slingluff

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Cancer Research|November 21, 1998
The peptide recognized by HLA-A68.2-restricted, squamous cell carcinoma of the lung-specific cytotoxic T lymphocytes is derived from a mutated elongation factor 2 geneK T Hogan, D P Eisinger, S B Cupp, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 14, 1998
Human melanoma patients recognize an HLA-A1-restricted CTL epitope from tyrosinase containing two cysteine residues: implications for tumor vaccine developmentD J Kittlesen, L W Thompson, P H Gulden, et al.
International Journal of Cancer|May 8, 2001
Evaluation of peptide vaccine immunogenicity in draining lymph nodes and peripheral blood of melanoma patientsG V Yamshchikov, D L Barnd, S Eastham, et al.
The Journal of Experimental Medicine|February 1, 1996
An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteinsJ C Skipper, R C Hendrickson, P H Gulden, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 7, 1998
Autologous human monocyte-derived dendritic cells genetically modified to express melanoma antigens elicit primary cytotoxic T cell responses in vitro: enhancement by cotransfection of genes encoding the Th1-biasing cytokines IL-12 and IFN-alphaT Tüting, C C Wilson, D M Martin, et al.
Melanoma Research|March 20, 2001
Gamma probe guided biopsy of the sentinel node in malignant melanoma: a multicentre studyS P Harlow, D N Krag, T Ashikaga, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2001
Phase I trial of a melanoma vaccine with gp100(280-288) peptide and tetanus helper peptide in adjuvant: immunologic and clinical outcomesC L Slingluff, G Yamshchikov, P Neese, et al.
Cancer Immunology, Immunotherapy : CII|February 7, 2001
Melanomas with concordant loss of multiple melanocytic differentiation proteins: immune escape that may be overcome by targeting unique or undefined antigensC L Slingluff, T A Colella, L Thompson, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Cancer Research|November 21, 1998
The peptide recognized by HLA-A68.2-restricted, squamous cell carcinoma of the lung-specific cytotoxic T lymphocytes is derived from a mutated elongation factor 2 geneK T Hogan, D P Eisinger, S B Cupp, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 14, 1998
Human melanoma patients recognize an HLA-A1-restricted CTL epitope from tyrosinase containing two cysteine residues: implications for tumor vaccine developmentD J Kittlesen, L W Thompson, P H Gulden, et al.
International Journal of Cancer|May 8, 2001
Evaluation of peptide vaccine immunogenicity in draining lymph nodes and peripheral blood of melanoma patientsG V Yamshchikov, D L Barnd, S Eastham, et al.
The Journal of Experimental Medicine|February 1, 1996
An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteinsJ C Skipper, R C Hendrickson, P H Gulden, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 7, 1998
Autologous human monocyte-derived dendritic cells genetically modified to express melanoma antigens elicit primary cytotoxic T cell responses in vitro: enhancement by cotransfection of genes encoding the Th1-biasing cytokines IL-12 and IFN-alphaT Tüting, C C Wilson, D M Martin, et al.
Melanoma Research|March 20, 2001
Gamma probe guided biopsy of the sentinel node in malignant melanoma: a multicentre studyS P Harlow, D N Krag, T Ashikaga, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2001
Phase I trial of a melanoma vaccine with gp100(280-288) peptide and tetanus helper peptide in adjuvant: immunologic and clinical outcomesC L Slingluff, G Yamshchikov, P Neese, et al.
Cancer Immunology, Immunotherapy : CII|February 7, 2001
Melanomas with concordant loss of multiple melanocytic differentiation proteins: immune escape that may be overcome by targeting unique or undefined antigensC L Slingluff, T A Colella, L Thompson, et al.
Pageof 6